Clinical Trial Update: EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the efficacy of Muscoril (methocarbamol) for neck myofascial syndromes. The study sponsored by Sanofi has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pain Syndrome

Drugs mentioned

• Muscoril (methocarbamol)

Snippet

Sponsor: Sanofi | Conditions: Myofascial Pain Syndromes | Phase 4 | Status: COMPLETED